UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.JCO2001225-3324

2020

Volltextzugriff (PDF)

Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.450-458

2015

Volltextzugriff (PDF)

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Journal of clinical oncology, 2011-04, Vol.29 (11), p.1465-1471

2011

Volltextzugriff (PDF)

A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

Clinical colorectal cancer, 2015-03, Vol.14 (1), p.1-10

2015

Volltextzugriff (PDF)

Guidelines for Antiemetic Treatment of Chemotherapy‐Induced Nausea and Vomiting: Past, Present, and Future Recommendations

The oncologist (Dayton, Ohio), 2007-09, Vol.12 (9), p.1143-1150

2007

Volltextzugriff (PDF)

Has the new TNM classification for colorectal cancer improved care?

Nature reviews. Clinical oncology, 2012-02, Vol.9 (2), p.119-123

2012

Volltextzugriff (PDF)

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

The lancet oncology, 2014-12, Vol.15 (13), p.1481-1492

2014

Volltextzugriff (PDF)

FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis

The oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.302-309

2021

Volltextzugriff (PDF)

MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside

Critical reviews in oncology/hematology, 2015-04, Vol.94 (1), p.31-44

2015

Volltextzugriff (PDF)

Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment

Journal of clinical oncology, 2004-04, Vol.22 (7), p.1209-1214

2004

Volltextzugriff (PDF)

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3588-3595

2012

Volltextzugriff (PDF)

Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer

European journal of cancer (1990), 2023-05, Vol.184, p.137-150

2023

Volltextzugriff (PDF)

Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model

Molecules (Basel, Switzerland), 2019-08, Vol.24 (16), p.2865

2019

Volltextzugriff (PDF)

A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer

Expert review of anticancer therapy, 2023-06, Vol.23 (6), p.633-641

2023

Volltextzugriff (PDF)

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: A Final Report of the AIO Colorectal Study Group

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4217-4222

2007

Volltextzugriff (PDF)

Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: Report of five cases

Arthritis & rheumatology (Hoboken, N.J.), 2011-08, Vol.63 (8), p.2540-2542

2011

Volltextzugriff (PDF)

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

Langenbeck's archives of surgery, 2013-03, Vol.398 (3), p.347-375

2013

Volltextzugriff (PDF)

Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5910-5917

2008

Volltextzugriff (PDF)

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity

PloS one, 2017-06, Vol.12 (6), p.e0178930-e0178930

2017

Volltextzugriff (PDF)

Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology

JNCI : Journal of the National Cancer Institute, 2022-06, Vol.114 (6), p.819-828

2022

Volltextzugriff (PDF)

Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1‐integrin‐dependent mechanism

International journal of cancer, 2016-02, Vol.138 (4), p.964-975

2016

Volltextzugriff (PDF)

Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2118-2123

2008

Volltextzugriff (PDF)

Presence of Mesenchymal Stem Cells in Human Bone Marrow After Exposure to Chemotherapy: Evidence of Resistance to Apoptosis Induction

Stem cells (Dayton, Ohio), 2006-12, Vol.24 (12), p.2753-2765

2006

Volltextzugriff (PDF)

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(351)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(377)
Deutsch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(166)
Humans
(164)
Oncology
(159)
Male
(85)
Female
(65)
Biological And Medical Sciences
(59)
Middle Aged
(58)
Medical Sciences
(57)
Adult
(56)
Aged
(56)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(53)
Chemotherapy
(51)
Tumors
(42)
Colorectal Neoplasms - Drug Therapy
(41)
Treatment Outcome
(41)
Colorectal Cancer
(40)
Fluorouracil - Administration & Dosage
(38)
Pharmacology. Drug Treatments
(31)
Colorectal Neoplasms - Pathology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

Guidelines for Antiemetic Treatment of Chemotherapy‐Induced Nausea and Vomiting: Past, Present, and Future Recommendations

Has the new TNM classification for colorectal cancer improved care?

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis

MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside

Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer

Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model

A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: A Final Report of the AIO Colorectal Study Group

Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: Report of five cases

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity

Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology

Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1‐integrin‐dependent mechanism

Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

Presence of Mesenchymal Stem Cells in Human Bone Marrow After Exposure to Chemotherapy: Evidence of Resistance to Apoptosis Induction

Suchergebnisse filtern